Clinical Trials Directory

Trials / Completed

CompletedNCT02020967

Programme of Acromegaly Screening in Patients With Associated Somatic Disorders

Programme of Acromegaly Screening in Patients With Associated Somatic Disorders, Who Are Observed at the Moscow Board of Health Endocrinology Dispensary and Endocrinology Hospital at First Moscow State Medical University for the Purpose of Early Identification of the Disease.

Status
Completed
Phase
Study type
Observational
Enrollment
367 (actual)
Sponsor
Ipsen · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of the protocol is to define percentage of patients with acromegaly in relation to the total number of screened patients with confirmed clinically significant set of associated somatic disorders with the help of laboratory (Insulin-like Growth Factor I, Growth Hormone, Oral Glucose-Tolerance Test \[IGF-1, GH, OGTT\]) and instrumental examination methods (Magnetic Resonance Imaging \[MRI\]).

Conditions

Interventions

TypeNameDescription
OTHERNon-interventional cross-sectional surveyThis is a survey which does not involve any intervention into routine clinical practice, including the use of any investigational therapy or special examination methods.

Timeline

Start date
2013-12-05
Primary completion
2015-09-15
Completion
2015-09-15
First posted
2013-12-25
Last updated
2021-05-26
Results posted
2021-04-28

Locations

2 sites across 1 country: Russia

Source: ClinicalTrials.gov record NCT02020967. Inclusion in this directory is not an endorsement.

Programme of Acromegaly Screening in Patients With Associated Somatic Disorders (NCT02020967) · Clinical Trials Directory